12VAC5-371-110. Management and administration.
A. No person shall own, establish, conduct, maintain, manage, or operate any nursing facility, as defined in § 32.1-123 of the Code of Virginia, without having obtained a license.
B. The nursing facility must comply with:
1. This chapter;
2. Other applicable federal, state, or local laws and regulations; and
3. The nursing facility's own policies and procedures.
C. The nursing facility shall submit or make available reports and information necessary to establish compliance with this chapter and applicable statutes.
D. The nursing facility shall permit representatives from the OLC to conduct inspections to:
1. Verify application information;
2. Determine compliance with this chapter;
3. Review necessary records; and
4. Investigate complaints.
E. The nursing facility shall fully disclose its admission policies, including any preferences given, to applicants for admission.
F. The nursing facility shall identify its operating elements and programs, the internal relationship among these elements and programs, and the management or leadership structure.
G. Unless the vaccination is medically contraindicated or the resident declines the offer of vaccination, the nursing facility shall provide or arrange for the administration to its residents of an annual influenza vaccination and a pneumococcal vaccination in accordance with the following recommendations of ACIP:
1. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022–23 Influenza Season, MMWR 71 (1), 2022, CDC;
2. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of ACIP - United States, MMWR 71 (4), 2022, CDC;
3. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged > 65 Years: Updated Recommendations of ACIP, MMWR 68 (46), 2019, CDC;
4. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of ACIP, MMWR 64 (34), 2015, CDC;
5. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged > 65 Years: Recommendations of ACIP, MMWR 63 (37), 2014, CDC;
6. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6 - 18 Years with Immunocompromising Conditions: Recommendations of ACIP, MMWR 62 (25), 2013, CDC;
7. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of ACIP, MMWR 61 (40), 2012, CDC;
8. Prevention of Pneumococcal Disease Among Infants and Children - Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of ACIP, MMWR 59 (RR-11), 2010, CDC; and
9. Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23), MMWR 59 (34), 2010, CDC.
H. Upon request of the nursing facility's family council, the nursing facility shall send notices and information about the family council mutually developed by the family council and the administration of the nursing facility, and provided to the nursing facility for such purpose, to the legal representative or a contact person of the resident's choice up to six times a year. Such notices may be included together with a monthly billing statement or other regular communication. Notices and information shall also be posted in a designated location within the nursing facility.
Statutory Authority
§§ 32.1-12 and 32.1-127 of the Code of Virginia.
Historical Notes
Derived from Virginia Register Volume 13, Issue 17, eff. July 1, 1997; amended, Virginia Register Volume 20, Issue 26, eff. September 27, 2004; Volume 23, Issue 10, eff. March 1, 2007; Volume 27, Issue 24, eff. September 1, 2011; Volume 37, Issue 17, eff. May 27, 2021; Volume 42, Issue 23, eff. August 13, 2026.